Insider Peter Farrell plans 2,000-share stock sale

A shareholder, Peter C Farrell, has filed a notice of intent to sell 2,000 shares of common stock through Merrill Lynch on the NYSE.

Accepted by SEC EDGAR 02/04/2026 - 06:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder, Peter C Farrell, has filed a notice of intent to sell 2,000 shares of common stock through Merrill Lynch on the NYSE. The planned sale has an aggregate market value of 502540, with 44,448,959 shares of the issuer’s stock reported as outstanding and an approximate sale date of 02/04/2026.

The 2,000 shares were acquired on 11/11/2014 via a stock option transaction for cash. Over the prior three months, Peter C Farrell sold 2,000 shares on each of three dates, with gross proceeds of 504020, 502860, and 497580, indicating a pattern of periodic share sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RMD shares is Peter C Farrell planning to sell?

Peter C Farrell plans to sell 2,000 shares of common stock. The notice lists an aggregate market value of 502540 for this block, with the transaction to be executed through Merrill Lynch on the NYSE around 02/04/2026.

At what approximate date will Peter C Farrells planned RMD share sale occur?

The planned sale is approximately dated 02/04/2026. The filing lists this date alongside the 2,000 common shares to be sold on the NYSE, providing investors a time frame for when the transaction may take place.

How were the 2,000 RMD shares to be sold by Peter C Farrell originally acquired?

The 2,000 shares were acquired on 11/11/2014 via a stock option transaction. The filing notes that the acquisition was paid in cash on that date, indicating a straightforward purchase rather than a gift or installment arrangement.

What recent RMD stock sales has Peter C Farrell made in the last three months?

The filing shows three recent sales of 2,000 common shares each. These occurred on 11/12/2025, 12/04/2025, and 01/07/2026, with gross proceeds of 504020, 502860, and 497580 respectively, indicating regular, similarly sized transactions.

How many shares of the issuers stock are reported as outstanding in this notice?

The notice reports 44,448,959 shares of the issuers common stock outstanding. This figure provides context for the relative size of Peter C Farrells planned 2,000-share sale compared with the total share base.

Through which broker and exchange will Peter C Farrell sell his RMD shares?

The planned 2,000-share sale will be executed through Merrill Lynch. The brokers address is listed in Los Angeles, and the transaction is expected to occur on the New York Stock Exchange (NYSE) according to the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001186102
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ResMed INC
SEC File Number	001-15317
Address of Issuer	9001 Spectrum Center Blvd San Diego CALIFORNIA 92123
Phone	858-746-2400
Name of Person for Whose Account the Securities are To Be Sold	Peter C Farrell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East, Ste 1200 Los Angeles CA 90067	2000	502540	44448959	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2014	Stock Option	Peter C Farrell			2000	11/11/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	11/12/2025	2000	504020
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	12/04/2025	2000	502860
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	01/07/2026	2000	497580

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Peter C Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)